Summary
A NEW medical advisory body is to examine whether emerging technology should be used to reduce the risk of variant CJD being passed through blood supplies.
The advisory committee on the safety of blood, tissues and organs (Sabto), an independent group which was set up last year to inform the UK health departments, is discussing whether screening tests, likely to become available in the next couple of years, should be used to prevent the possible transmission of the human form of BSE.See the full content of this document
Extract
New Body to Cut Cjd in Blood Stocks Health: Risks
In the UK, four people are thought to have developed vCJD after receiving blood fr...
See the full content of this document
Sponsored links
